NVP-BGT226 200mg

NVP-BGT226, novel phosphoinositide 3-kinase/mTOR dual inhibitor, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo.

Price Not Available 200mg NVP-BGT226 200mg Supplier Page

Trivial name	NVP-BGT226 200mg
Catalog Number	A11162-200
Alternative Name(s)	1-(3-(Trifluoromethyl)-4-(piperazin-1-yl)phenyl)-8-(6-methoxypyridin-3-yl)-3-methyl-1H-imidazo[4,5-c]quinolin-2(3H)-one maleic acid salt
Molecular Formula	C28H25F3N6O2.C4H4O4
CAS#	1245537-68-1
SMILES	CN1C2=CN=C3C=CC(=CC3=C2N(C1=O)C4=CC(=C(C=C4)N5CCNCC5)C(F)(F)F)C6=CN=C(C=C6)OC.C(=CC(=O)O)C(=O)O
Size	200mg
Supplier Page	http://www.adooq.com/nvp-bgt226.html